Andrew James Hill
Senior Vice President of Operations & DevelopmentMr. Andrew James Hill, also known as Drew, serves as an Executive Vice President of Research & Development at Paragon 28, Inc. since joining in October 2023, leading a team inclusive of Engineering, Clinical Affairs, Disior and Patient Specific Implants. Drew has experience across the medical device, pharmaceutical and consumer products space. From 2018 to joining Paragon 28 in 2023, he held various leadership roles with ViewRay Systems, Inc. (formerly known as ViewRay, Inc.)luding Senior Vice President of Operations and Development and Vice President of Manufacturing. Prior to ViewRay, Drew was the Director of Operations of the Colorado Springs location of Philips Image Guided Therapy, formerly Spectranetics and prior to Spectranetics he held various roles at GSK Vaccines, formerly Novartis Vaccines. Mr. Hill holds a M.B.A. from Massachusetts Institute of Technology. Mr. Hill has M.S. in Chemical Engineering from Massachusetts Institute of Technology. Mr. Hill has B.S. in Chemical Engineering from University of Florida.
Positions
- Company NameViewRay Systems, Inc.Stock CodeVRAYQPositionSenior Vice President of Operations & DevelopmentColleagues
- PZPaul ZieglerPresident, CEO & Director
- DJDaniel Jeffrey MooreIndependent Chairman
- JFJames F. DempseyFounder & Chief Scientific Officer
- MHMatt HarrisonDirector of Investor Relations
- SSSanket ShahSenior VP & General Counsel
- BKBrian K. RobertsIndependent Director
- BKB. Kristine JohnsonIndependent Director
- SWScott William DrakeDirector
